Clinical trial NCT03617874 - References

Human Immunodeficiency Virus Transmission — PC4PrEP: Integrating PrEP Into Primary Care

Citation(s)

•   Ajzen I, Madden TJ
  Prediction of goal-directed behavior: attitudes, intentions, and perceived behavioral control. Journal of Experimental Social Psychology. 1986;22(5):453-474
•   Ajzen I, The theory of planned behavior
  Organizational Behavior and Human Decision Process. 1991;50(2):179-211
•   Arnold EA, Hazelton P, Lane T, Christopoulos KA, Galindo GR, Steward WT, Morin SF
  A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603. doi: 10.1371/journal.pone.0040603. Epub 2012 Jul 11.
•   Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team
  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.
•   Bandura A
  Human agency in social cognitive theory. Am Psychol. 1989 Sep;44(9):1175-84.
•   Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD; VISION/VAX004 Study Team
  HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101.
•   Bauman LJ, Braunstein S, Calderon Y, Chhabra R, Cutler B, Leider J, Rivera A, Sclafane J, Tsoi B, Watnick D
  Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr. 2013 Nov 1;64 Suppl 1:S20-6. doi: 10.1097/QAI.0b013e3182a99c19.
•   Bauman LJ, Wright E, Leickly FE, Crain E, Kruszon-Moran D, Wade SL, Visness CM
  Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics. 2002 Jul;110(1 Pt 1):e6.
•   Beyrer C, Bekker LG, Pozniak A, Barré-Sinoussi F
  Pre-exposure prophylaxis works--it's time to deliver. Lancet. 2015 Apr 18;385(9977):1482-4. doi: 10.1016/S0140-6736(15)60724-3.
•   Bronfenbrenner U, Ceci SJ
  Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. 1994 Oct;101(4):568-86.
•   Brooks RA, Landovitz RJ, Regan R, Lee SJ, Allen VC Jr
  Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2015 Dec;26(14):1040-8. doi: 10.1177/0956462415570159. Epub 2015 Jan 30.
•   Cáceres CF, O'Reilly KR, Mayer KH, Baggaley R
  PrEP implementation: moving from trials to policy and practice. J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20222. doi: 10.7448/IAS.18.4.20222. eCollection 2015.
•   Campbell JD, Herbst JH, Koppenhaver RT, Smith DK
  Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV. Am J Prev Med. 2013 Jan;44(1 Suppl 2):S63-9. doi: 10.1016/j.amepre.2012.09.045. Review.
•   Carlfjord S, Lindberg M, Bendtsen P, Nilsen P, Andersson A
  Key factors influencing adoption of an innovation in primary health care: a qualitative study based on implementation theory. BMC Fam Pract. 2010 Aug 23;11:60. doi: 10.1186/1471-2296-11-60.
•   Castel AD, Feaster DJ, Tang W, Willis S, Jordan H, Villamizar K, Kharfen M, Kolber MA, Rodriguez A, Metsch LR
  Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP. J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):520-8. doi: 10.1097/QAI.0000000000000780.
•   Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, Anderson PL
  Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013 Feb;29(2):384-90. doi: 10.1089/AID.2012.0089. Epub 2012 Oct 10.
•   Celum C, Baeten JM
  Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis. 2012 Feb;25(1):51-7. doi: 10.1097/QCO.0b013e32834ef5ef. Review.
•   Centers for Disease Control and Prevention (CDC)
  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9.
•   Centers for Disease Control and Prevention (CDC)
  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8.
•   Centers for Disease Control and Prevention (CDC)
  Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):463-5.
•   Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu AY
  High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):439-48. doi: 10.1097/QAI.0000000000000479.
•   Collins LM, Murphy SA, Strecher V
  The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. Am J Prev Med. 2007 May;32(5 Suppl):S112-8.
•   Cook PF, Friedman R, Lord A, Bradley-Springer LA
  Outcomes of multimodal training for healthcare professionals at an AIDS education and training center. Eval Health Prof. 2009 Mar;32(1):3-22. doi: 10.1177/0163278708328736. Epub 2009 Jan 8.
•   Corneli AL, McKenna K, Perry B, Ahmed K, Agot K, Malamatsho F, Skhosana J, Odhiambo J, Van Damme L
  The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):578-84. doi: 10.1097/QAI.0000000000000525.
•   Crain EF, Mortimer KM, Bauman LJ, Kercsmar CM, Weiss KB, Wissow L, Mitchell H, Rotor D
  Pediatric asthma care in the emergency department: measuring the quality of history-taking and discharge planning. J Asthma. 1999;36(1):129-38.
•   Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C
  Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
•   Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A
  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999 Sep 1;282(9):867-74.
•   Diiorio CA, Kobau R, Holden EW, Berkowitz JM, Kamin SL, Antonak RF, Austin JK, Baker GA, Bauman LJ, Gilliam F, Thurman DJ, Price PH
  Developing a measure to assess attitudes toward epilepsy in the US population. Epilepsy Behav. 2004 Dec;5(6):965-75.
•   Drainoni ML, Dekker D, Lee-Hood E, Boehmer U, Relf M
  HIV medical care provider practices for reducing high-risk sexual behavior: results of a qualitative study. AIDS Patient Care STDS. 2009 May;23(5):347-56. doi: 10.1089/apc.2008.0063.
•   Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway-Washington C
  Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with Men. AIDS Patient Care STDS. 2015 Aug;29(8):423-9. doi: 10.1089/apc.2014.0303. Epub 2015 Jun 17.
•   Epstein RM, Morse DS, Frankel RM, Frarey L, Anderson K, Beckman HB
  Awkward moments in patient-physician communication about HIV risk. Ann Intern Med. 1998 Mar 15;128(6):435-42.
•   Exner TM, Mantell JE, Adeokun LA, Udoh IA, Ladipo OA, Delano GE, Faleye J, Akinpelu K
  Mobilizing men as partners: the results of an intervention to increase dual protection among Nigerian men. Health Educ Res. 2009 Oct;24(5):846-54. doi: 10.1093/her/cyp021. Epub 2009 Apr 9.
•   Flash C, Landovitz R, Giler RM, Ng L, Magnuson D, Wooley SB, Rawlings K
  Two years of Truvada for pre-exposure prophylaxis utilization in the US. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19730. doi: 10.7448/IAS.17.4.19730. eCollection 2014.
•   Flodgren G, Parmelli E, Doumit G, Gattellari M, O'Brien MA, Grimshaw J, Eccles MP
  Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD000125. doi: 10.1002/14651858.CD000125.pub4. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 24;6:CD000125.
•   Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF; rgp120 HIV Vaccine Study Group
  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis. 2005 Mar 1;191(5):654-65. Epub 2005 Jan 27.
•   Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV; iPrEx study team
  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
•   Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O
  Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581-629. Review.
•   Guidance on Pre-Exposure Oral Prophylaxis (PrEP) for Serodiscordant Couples, Men and Transgender Women Who Have Sex with Men at High Risk of HIV: Recommendations for Use in the Context of Demonstration Projects
  Geneva: World Health Organization; 2012 Jul.
•   Hettema J, Steele J, Miller WR
  Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. Review.
•   Hoffman S, Guidry JA, Collier KL, Mantell JE, Boccher-Lattimore D, Kaighobadi F, Sandfort TG
  A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox". J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):59-65. doi: 10.1177/2325957415600798. Epub 2015 Aug 20.
•   Hollway W, Jefferson T
  Eliciting narrative through the in-depth interview. Qualitative Inquiry. 3(1): 53-70, 1997.
•   Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, Rutledge B, Martinez J, Garofalo R, Wilson CM; Adolescent Trials Network for HIVAIDS Interventions (ATN)
  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56. doi: 10.1097/QAI.0b013e3182801081.
•   Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, Nakku-Joloba E, Njuguna S, Mugo N, Bukusi E, Manongi R, Baeten JM; Partners in Prevention HSVHIV Transmission Study and the Partners PrEP Study Teams
  An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):339-47. doi: 10.1097/QAI.0b013e31827e622d.
•   Karasz A, Singelis TM
  Qualitative and Mixed Methods Research in Cross-cultural Psychology: Introduction to the Special Issue. J Cross Cult Psychol. 2009 Nov 1;40(6):909-916.
•   Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM
  Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis. 2014 Mar;58(5):704-12. doi: 10.1093/cid/cit796. Epub 2013 Dec 6.
•   Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, Rosenberg ES
  Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia. Clin Infect Dis. 2015 Nov 15;61(10):1590-7. doi: 10.1093/cid/civ664. Epub 2015 Aug 13. Review.
•   Kelly JA, Somlai AM, Benotsch EG, McAuliffe TL, Amirkhanian YA, Brown KD, Stevenson LY, Fernandez MI, Sitzler C, Gore-Felton C, Pinkerton SD, Weinhardt LS, Opgenorth KM
  Distance communication transfer of HIV prevention interventions to service providers. Science. 2004 Sep 24;305(5692):1953-5.
•   Kelly JA, Somlai AM, DiFranceisco WJ, Otto-Salaj LL, McAuliffe TL, Hackl KL, Heckman TG, Holtgrave DR, Rompa D
  Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. Am J Public Health. 2000 Jul;90(7):1082-8.
•   King HL, Keller SB, Giancola MA, Rodriguez DA, Chau JJ, Young JA, Little SJ, Smith DM
  Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS Behav. 2014 Sep;18(9):1722-5. doi: 10.1007/s10461-014-0845-5.
•   Kirby T, Thornber-Dunwell M
  Uptake of PrEP for HIV slow among MSM. Lancet. 2014 Feb 1;383(9915):399-400.
•   Koblin B, Chesney M, Coates T; EXPLORE Study Team
  Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004 Jul 3-9;364(9428):41-50.
•   Krakower D, Mayer KH
  Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012 Nov;7(6):593-9. doi: 10.1097/COH.0b013e3283590446. Review.
•   Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH
  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014 Sep;18(9):1712-21. doi: 10.1007/s10461-014-0839-3.
•   Levin B
  The utility of futility. Stroke. 2005 Nov;36(11):2331-2. Epub 2005 Oct 13.
•   Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, Buchbinder S
  Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014 Mar 4;11(3):e1001613. doi: 10.1371/journal.pmed.1001613. eCollection 2014 Mar.
•   Majumdar SR, Tsuyuki RT, McAlister FA
  Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J. 2007 Jan;153(1):22.e1-8.
•   Mantell JE, Exner TM, Cooper D, Bai D, Leu CS, Hoffman S, Myer L, Moodley J, Kelvin EA, Constant D, Jennings K, Zweigenthal V, Stein ZA
  Pregnancy intent among a sample of recently diagnosed HIV-positive women and men practicing unprotected sex in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S202-9. doi: 10.1097/QAI.0000000000000369.
•   Mantell JE, Sandfort TG, Hoffman S, Guidry JA, Masvawure TB, Cahill S
  Knowledge and Attitudes about Pre-Exposure Prophylaxis (PrEP) among Sexually Active Men Who Have Sex with Men (MSM) Participating in New York City Gay Pride Events. LGBT Health. 2014 Mar 13;1(2):93-97.
•   Mayer KH, Krakower DS
  Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation. Clin Infect Dis. 2015 Nov 15;61(10):1598-600. doi: 10.1093/cid/civ665. Epub 2015 Aug 13.
•   McDougal SJ, Alexander J, Dhanireddy S, Harrington RD, Stekler JD
  Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington. PLoS One. 2014 Aug 20;9(8):e105030. doi: 10.1371/journal.pone.0105030. eCollection 2014.
•   Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH
  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83. doi: 10.1097/QAI.0b013e31818d5a27.
•   Mimiaga MJ, Goldhammer H, Belanoff C, Tetu AM, Mayer KH
  Men who have sex with men: perceptions about sexual risk, HIV and sexually transmitted disease testing, and provider communication. Sex Transm Dis. 2007 Feb;34(2):113-9.
•   Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH
  Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2014;26(6):684-93. doi: 10.1080/09540121.2013.845289. Epub 2013 Oct 14.
•   Molina JM, Pintado C, Gatey C, Ponscarme D, Charbonneau P, Loze B, Rozenbaum W, Delaugerre C
  Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe? BMC Med. 2013 Aug 23;11:186. doi: 10.1186/1741-7015-11-186. Review.
•   Morin SF, Koester KA, Steward WT, Maiorana A, McLaughlin M, Myers JJ, Vernon K, Chesney MA
  Missed opportunities: prevention with HIV-infected patients in clinical care settings. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):960-6.
•   Morin SF, Yamey G, Rutherford GW
  HIV pre-exposure prophylaxis. BMJ. 2012 Aug 13;345:e5412. doi: 10.1136/bmj.e5412.
•   Nadeem E, Olin SS, Hill LC, Hoagwood KE, Horwitz SM
  Understanding the components of quality improvement collaboratives: a systematic literature review. Milbank Q. 2013 Jun;91(2):354-94. doi: 10.1111/milq.12016. Review.
•   Nair H, Manchanda P, Bhatia T
  Asymmetric social interactions in physician prescription behavior: The role of opinion Leaders. Journal of Marketing Research 47(5): 883-895, 2010.
•   Norton WE, Larson RS, Dearing JW
  Primary care and public health partnerships for implementing pre-exposure prophylaxis. Am J Prev Med. 2013 Jan;44(1 Suppl 2):S77-9. doi: 10.1016/j.amepre.2012.09.037. Review.
•   Okun A, Stein RE, Bauman LJ, Silver EJ
  Content validity of the Psychiatric Symptom Index, CES-depression Scale, and State-Trait Anxiety Inventory from the perspective of DSM-IV. Psychol Rep. 1996 Dec;79(3 Pt 1):1059-69.
•   Palesch YY, Tilley BC
  An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:55-6.
•   Pequegnat W, Szacpocznik J, Bauman LJ, et al
  Measurement relevant to the role of families in prevention and adaptation to HIV/AIDS. AIDS and Behavior. 2001;5(1):1-19.
•   Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G
  Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis. 2013 May 14;13:217. doi: 10.1186/1471-2334-13-217.
•   Remien RH, Bauman LJ, Mantell JE, Tsoi B, Lopez-Rios J, Chhabra R, DiCarlo A, Watnick D, Rivera A, Teitelman N, Cutler B, Warne P
  Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S16-24. doi: 10.1097/QAI.0000000000000577.
•   Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW
  Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):421-7. doi: 10.1097/QAI.0b013e318256b2f6.
•   Stein RE, Bauman LJ, Epstein SG, Gardner JD, Walker DK
  How well does the questionnaire for identifying children with chronic conditions identify individual children who have chronic conditions? Arch Pediatr Adolesc Med. 2000 May;154(5):447-52.
•   Stein RE, Westbrook LE, Bauman LJ
  The Questionnaire for Identifying Children with Chronic Conditions: a measure based on a noncategorical approach. Pediatrics. 1997 Apr;99(4):513-21.
•   Tellalian D, Maznavi K, Bredeek UF, Hardy WD
  Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013 Oct;27(10):553-9. doi: 10.1089/apc.2013.0173. Epub 2013 Sep 20.
•   Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K
  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ. 2009 May 12;180(10):E47-57. doi: 10.1503/cmaj.090523. Epub 2009 Apr 16.
•   Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA
  Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J. 2012 Apr;105(4):199-206. doi: 10.1097/SMJ.0b013e31824f1a1b.
•   Vanable PA, Ostrow DG, McKirnan DJ
  Viral load and HIV treatment attitudes as correlates of sexual risk behavior among HIV-positive gay men. J Psychosom Res. 2003 Mar;54(3):263-9.
•   Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR
  What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8. doi: 10.1097/QAI.0b013e31824a060b.
•   Wheelock A, Eisingerich AB, Gomez GB, Gray E, Dybul MR, Piot P
  Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open. 2012 Jul 2;2(4). pii: e001234. doi: 10.1136/bmjopen-2012-001234. Print 2012.
•   White JM, Mimiaga MJ, Krakower DS, Mayer KH
  Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012 Jul;26(7):395-405. doi: 10.1089/apc.2012.0030. Epub 2012 Jun 13.
•   Wilson IB, Fowler FJ Jr, Cosenza CA, Michaud J, Bentkover J, Rana A, Kogelman L, Rogers WH
  Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2014 Dec;18(12):2349-58.

PC4PrEP: Integrating Pre-Exposure Prophylaxis (PrEP) Into Primary Care

Details for clinical trial NCT03617874